STAGE III LUNG CANCER AJCC V8

This study looked at 20 adults with stage 2-3 non-small cell lung cancer that could not be removed by surgery. Participants received standard chemotherapy along with different doses of proton beam therapy to find the safest and most effective dose. The goal was to improve cancer …

This early-stage trial tested whether adding immunotherapy drugs (durvalumab, monalizumab, or oleclumab) to radiation therapy is safe for people with advanced non-small cell lung cancer that cannot be removed by surgery. The study involved 26 participants and focused on side effe…

This study tested a health coaching program called BeWell360-CG for caregivers of people with advanced lung cancer. The goal was to see if coaching could reduce caregiver stress and improve their quality of life. About 55 caregivers took part, and researchers measured changes in …

This study collected blood and tumor tissue from 64 people with advanced or treatment-resistant cancers. Researchers stored these samples to study how genes affect cancer growth and response to therapy. The goal is to better understand why some cancers stop responding to treatmen…

This study involved 24 people with lung or esophageal cancer receiving radiation therapy near the heart. Researchers used a small implanted device to continuously monitor heart activity for up to a year. The goal was to detect early heart changes that might otherwise go unnoticed…